ISTA should have a decision on the 16th, it's my top pick in this segment, however I'm in BIOD and MNKD as well. I don't think MNKD's Alfreeza is going to gain approval though so I may sell before the decision, it's a ways off so I still have time to decide. Good luck!
BIOD is a "Pay me now or pay me later" stock. If they get a CRL this month, they'll get approved within a year. At only a $130 million market capitalization, that stock will be a 5-bagger. My top speculative pick.
MNKD is another. It will likely get its inhaled insulin approved in December. That stock will triple on that news.
For now, hold ALKS through the PDUFA for Bydureon. It's a lock. $19 per share upon that approval.